These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18770437)

  • 1. Differential effect of maternal antibodies on efficacy of cellular and cell-free Marek's disease vaccines.
    Witter RL; Burmester BR
    Avian Pathol; 1979 Apr; 8(2):145-56. PubMed ID: 18770437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the efficacy against Marek's disease of cell-free and cell-associated turkey herpesvirus vaccine.
    Eidson CS; Villegas P; Page RK; Kleven SH
    Avian Dis; 1975; 19(3):515-24. PubMed ID: 1164319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of maternal immunity against development of Marek's disease and protective ability of vaccine.
    Yoshida I; Yuasa N; Horiuchi T; Tsubahara H
    Natl Inst Anim Health Q (Tokyo); 1975; 15(1):1-7. PubMed ID: 804667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyvalent Marek's disease vaccines: safety, efficacy and protective synergism in chickens with maternal antibodies.
    Witter RL; Lee LF
    Avian Pathol; 1984 Jan; 13(1):75-92. PubMed ID: 18766823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
    Sharma JM; Graham CK
    Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vaccine dose, virus challenge dose and interval from vaccination to challenge on protection of broiler chickens against Marek's disease virus challenge.
    Islam AF; Walkden-Brown SW; Groves PJ; Underwood GJ
    Aust Vet J; 2007 Sep; 85(9):348-55. PubMed ID: 17760936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection by attenuated and polyvalent vaccines against highly virulent strains of Marek's disease virus.
    Witter RL
    Avian Pathol; 1982; 11(1):49-62. PubMed ID: 18770172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
    Nazerian K; Witter RL; Lee LF; Yanagida N
    Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marek's disease tumors in chickens vaccinated with turkey herpesvirus vaccine.
    Eidson CS
    Dev Biol Stand; 1982; 52():437-46. PubMed ID: 7166202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Potency tests with HVT-, MHV- and JMV vaccines against Marek's disease].
    Landgraf H; Vielitz E
    Avian Pathol; 1978 Apr; 7(2):193-202. PubMed ID: 18770372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers.
    Witter RL; Sharma JM; Lee LF; Opitz HM; Henry CW
    Avian Dis; 1984; 28(1):44-60. PubMed ID: 6326743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
    de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
    Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Marek's disease vaccines: protection and viraemia studies with turkey herpes virus vaccines.
    Thornton DH; Hinton MH; Muskett JC
    Avian Pathol; 1975; 4(2):97-108. PubMed ID: 18777298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marek's disease control: comparative efficacy of cell-associated and cell-free lyophilized HVT vaccine.
    Zanella A; Granelli G
    Avian Pathol; 1974 Jan; 3(1):45-50. PubMed ID: 18777256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the turkey herpesvirus vaccine by the aerogenic route for the prevention of Marek's disease.
    Eidson CS; Kleven SH
    Dev Biol Stand; 1976; 33():370-5. PubMed ID: 182596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-protection between JMV Marek's disease-derived tumour transplant, Marek's disease and turkey herpesviruses.
    Bulow VV
    Avian Pathol; 1977; 6(4):353-66. PubMed ID: 18770345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference between influences of homologous and heterologous maternal antibodies on response to serotype-2 and serotype-3 Marek's disease vaccines.
    King D; Page D; Schat KA; Calnek BW
    Avian Dis; 1981; 25(1):74-81. PubMed ID: 6268052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Marek's disease: a review.
    Purchase HG
    Cancer Res; 1976 Feb; 36(2 pt 2):696-700. PubMed ID: 766959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
    Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
    Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.